Breakout

Cannabis Use Disorder in a High-Potency Era: Practical Assessment and Treatment Across Populations

90 min
Saturday, June 05, 2027
3:15 PM - 4:45 PM
Session Description: Cannabis use disorder is the most common drug use disorder in the United States: in 2024, 20.6 million people aged 12 and older, or 7.1 percent, met criteria (SAMHSA, 2025). Clinicians across settings see it routinely, often alongside another substance or a mental health condition, yet many were trained when products were far weaker than what clients use today. This session gives experienced clinicians a current, practical approach. It opens with what today's flower, concentrates, vapes, edibles, and hemp-derived products deliver, and why dose and daily use predict risk better than product type. It then works through the presentations most often missed or misread: withdrawal mistaken for an anxiety disorder, cannabinoid hyperemesis syndrome, cannabis-associated psychosis, and the bidirectional links with depression, anxiety, and sleep. The final third focuses on treatment: the approaches with the strongest evidence, including motivational enhancement, cognitive behavioral therapy, and contingency management, and the adjustments that matter for adolescents and young adults, pregnant and parenting clients, older adults, clients with serious mental illness, and clients receiving medication for opioid use disorder. The session closes with what research does and does not support about therapeutic use, so clinicians can respond credibly when clients describe cannabis as medicine. Participants leave with a five-question product history for intake, a withdrawal plan for the first two weeks of reduced use, a three-question screen for cannabinoid hyperemesis syndrome, and goal-setting language for clients who want to cut back rather than stop.
share
Back to top